The imbalance of this immune balance is a significant cause of RA (66, 95, 96) Therefore, increasing peripheral blood Tregs in RA patients, reducing Th17 or IL-17A levels, and improving the Treg/Th17 cell imbalance may be key to RA treatment (Figure 2). Here, IL17A is linked to rheumatoid arthritis.